Monday, May 10, 2021

Private equity fund invests in Charnwood Molecular

Synova, a European private equity fund, has made a significant investment into Charnwood Molecular, facilitating the business’s expansion plans.

The deal has provided the company with additional capital to support its future development and growth, including the introduction of additional senior leadership team members into the business.

Charnwood Molecular’s growth plan now sees the company becoming the sole occupier of a substantial 3-storey, state-of-the-art laboratory facility at Charnwood Campus, Loughborough.

Charnwood Campus is a science, innovation and technology park set in 70 acres of landscaped grounds in Loughborough. The campus was recently designated a ‘Life Sciences Opportunity Zone’, providing an environment to inspire discovery, encourage collaboration and accelerate business growth within the Med-Tech and Biopharma industries.

Charnwood Molecular has seen significant expansion of its global client base in recent years and this latest physical expansion of the business will support its growth plan across a wide range of contract research services: from medicinal chemistry, chemical development and early process research through to developing a suite of complementary services in order to provide a holistic pre-clinical discovery portfolio to its international client base.

CEO of Charnwood Molecular, Steve Allin, said: “The truly world-class facilities at Charnwood Campus provide us with a key piece in our strategic plan to become the provider of choice for integrated drug discovery and development services within the global life sciences sector.

“The new laboratories will provide substantial capacity for future growth and expansion of our medicinal chemistry and process research teams, along with the addition of related drug discovery service lines.”

John Handley, Managing Director of Charnwood Molecular, added: “Our expansion plans for the business are now coming to fruition. From hiring significant numbers of new scientists at both of our existing research sites, through to a doubling of our business development team and now adding much larger bespoke facilities, we are looking to the future to make Charnwood Molecular a very major player in the discovery CRO marketplace.”

Gosia Khrais, Commercial and Marketing Director at Charnwood Campus, said: “It is a great pleasure to welcome Charnwood Molecular as a new occupier here. This fantastic CRO with ambitious growth plans will cement life sciences as a priority sector in the region, create jobs and help us grow our local economy. It is really great news for Loughborough.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.






Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close